|
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the case information and related record review, a conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.Renal failure is listed in the xience alpine everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
It was reported that two xience alpine stents, 2.25 x 12 and 4.0 x 15 mm) were implanted on (b)(6) 2016.On (b)(6) 2016, the patient was re-admitted with bi-lateral weakness / falls / acute renal failure.It is unknown what treatment was provided.No additional information was provided.
|